HOME >> MEDICINE >> NEWS
Clevidipine during heart surgery improves blood pressure control

Researchers today reported that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiologys 56th Annual Scientific Session. Another study found that measuring a certain peptide can help evaluate dyspnea (shortness of breath) as heart- or lung-related in the general population. ACC.07 is the premier cardiovascular medical meeting, bringing together specialists from around the world to further breakthroughs in cardiovascular medicine.

Blood Pressure Control With Clevidipine Compared With Nitroglycerin, Sodium Nitroprusside, or Nicardipine in the Treatment of Perioperative Hypertension: Results of the Three Randomized ECLIPSE Trials (Presentation Number: 415-8)

While nitroglycerin and sodium nitroprusside have been utilized effectively in patients undergoing cardiac surgery to control blood pressure, a new therapy called clevidipine may perform even better, according to researchers at Duke University School of Medicine. Three separate studies evaluated clevidipine, a novel third-generation intravenous (IV) dihydropyridine calcium channel blocker, to measure blood pressure control against standard alternative agents.

The studies, collectively known as ECLIPSE (Evaluation of CLevidipine In the Postoperative Treatment of Hypertension Assessing Safety Events), compared clevidipine to each of three standard therapies: nitroglycerin, nitroprusside or nicardipine. The studies assessed blood pressure control by calculating the magnitude and duration of episodes when patients blood pressure went above or below predetermined acceptable ranges, based on the area under the blood-pressure-monitoring curve (AUC) that was outside the upper or lower limits of the range during surgery and for 24 hours afterwards.

The first two ECLIPSE studies found that patients treated wi
'"/>

Contact: Leslie Humbel
lhumbel@spectrumscience.com
504-613-2418
American College of Cardiology
27-Mar-2007


Page: 1 2 3

Related medicine news :

1. Michigan-CDC study supports value of social restrictions during influenza pandemics
2. Are parking garages safe during hurricanes?
3. Smoking may interfere with alcoholics neurocognitive recovery during abstinence
4. Genetic variations may predispose some men to suicidal thoughts during treatment for depression
5. Study questions risks of anti-bleeding drug during heart surgery
6. Pfizer Onocology press briefing scheduled during ASCO 2007 Annual Meeting
7. UW study to clarify safety, effectiveness of hormone therapy during menopause
8. Eating apples and fish during pregnancy may protect against childhood asthma and allergies
9. Clinical guidelines for blood conservation during cardiac procedures developed
10. Aspirin use during pregnancy could reduce risk of pre-eclampsia
11. Will the healthcare workers go to work during disasters?

Post Your Comments:
(Date:7/30/2015)... , ... July 30, 2015 , ... ... the ‘Mary Jo Lawyer-Spano Mesothelioma Patient Registry Act of 2015’. The bill ... Chris Collins (R-NY), Peter King (R-NY), Betty McCollum (D-MN), Joe Kennedy (D-MA), and ...
(Date:7/30/2015)... ... , ... Using the latest online digital technologies, happiness expert Kay Walker is ... and manage major depression. , “Suicide is 100% preventable. The problem is the medical ... and die needlessly everyday,” says Walker. “I’m out to end suicide. Some may say ...
(Date:7/30/2015)... ... July 30, 2015 , ... Boston Web ... annual All-Stars Summit. Google Partners is the platform for search marketing agencies to ... support and tools necessary to run successful search marketing campaigns. Google Partners also ...
(Date:7/30/2015)... ... July 30, 2015 , ... Between 2012 and 2014 HIV infection rates ... Florida on June 17th. Those untreated heroin use disorders share their needles and ... of dirty needles throughout the community. Ultimately Florida’s HIV infection rates have bolstered to ...
(Date:7/30/2015)... ... 30, 2015 , ... Ocean Hills Recovery has officially been accredited by CARF ... No recommendations means CARF found no areas in the OHR program that needed improvement, ... of all facilities receive. In addition, Ocean Hills was granted the maximum certification period ...
Breaking Medicine News(10 mins):Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2
(Date:7/30/2015)... BURLINGAME, Calif. , July 30, 2015 /PRNewswire/ ... Patent and Trademark Office has granted the company ... property covering Cleave,s lead molecule CB-5083. ... quinazolines as inhibitors of p97," U.S. 9,062,026, allows ... CB-5083, a first-in-class, highly selective oral inhibitor of ...
(Date:7/30/2015)... , July 30, 2015  Alimera Sciences, Inc. (NASDAQ: ... in the research, development and commercialization of prescription ophthalmic ... quarter fiscal year 2015 financial results after the market ... call will follow on the same day at 4:30 ... President and Chief Executive Officer, and Rick Eiswirth ...
(Date:7/30/2015)...   HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the ... revenue of $73.6 million for the quarter ended ... the quarter ended June 30, 2014.  Currency fluctuations ... nine percentage points, during the three months ended ...
Breaking Medicine Technology:Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results 2HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 2HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 3HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 4HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 5HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 6HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 7HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 8HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 9HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 10HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 11HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 12HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 13HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 14
Cached News: